Literature DB >> 24742772

Implementation of design of experiments for optimization of forced degradation conditions and development of a stability-indicating method for furosemide.

Moolchand Kurmi1, Sanjay Kumar1, Bhupinder Singh2, Saranjit Singh3.   

Abstract

The study involved optimization of forced degradation conditions and development of a stability-indicating method (SIM) for furosemide employing the design of experiment (DoE) concept. The optimization of forced degradation conditions, especially hydrolytic and oxidative, was done by application of 2(n) full factorial designs, which helped to obtain the targeted 20-30% drug degradation and also enriched levels of degradation products (DPs). For the selective separation of the drug and its DPs for the development of SIM, DoE was applied in three different stages, i.e., primary parameter selection, secondary parameter screening and method optimization. For these three, IV-optimal, Taguchi orthogonal array and face-centred central composite designs were employed, respectively. The organic modifier, buffer pH, gradient time and initial hold time were selected as primary parameters. Initial and final organic modifier percentage, and flow rate came out as critical parameters during secondary parameter screening, which were further evaluated during method optimization. Based on DoE results, an optimized method was obtained wherein a total of twelve DPs were separated successfully. The study also exposed the degradation behaviour of the drug in different forced degradation conditions.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Degradation products; Design of experiment; Furosemide; Stability-indicating method

Mesh:

Substances:

Year:  2014        PMID: 24742772     DOI: 10.1016/j.jpba.2014.03.035

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  5 in total

1.  Stability of furosemide and chlorothiazide stored in syringes.

Authors:  Jeffrey J Cies; Wayne S Moore; Arun Chopra; Guizhen Lu; Robert W Mason
Journal:  Am J Health Syst Pharm       Date:  2015-12-15       Impact factor: 2.637

2.  Comparison of pharmacokinetic parameters of ranolazine between diabetic and non-diabetic rats.

Authors:  Habibeh Mashayekhi-Sardoo; Hossein Kamali; Soghra Mehri; Amirhossein Sahebkar; Mohsen Imenshahidi; Amir Hooshang Mohammadpour
Journal:  Iran J Basic Med Sci       Date:  2022-07       Impact factor: 2.532

3.  Development and Validation of Stability-Indicating Method for Estimation of Chlorthalidone in Bulk and Tablets with the Use of Experimental Design in Forced Degradation Experiments.

Authors:  Sandeep Sonawane; Sneha Jadhav; Priya Rahade; Santosh Chhajed; Sanjay Kshirsagar
Journal:  Scientifica (Cairo)       Date:  2016-03-31

4.  Analytical Quality by Design Approach in RP-HPLC Method Development for the Assay of Etofenamate in Dosage Forms.

Authors:  R Peraman; K Bhadraya; Y Padmanabha Reddy; C Surayaprakash Reddy; T Lokesh
Journal:  Indian J Pharm Sci       Date:  2015 Nov-Dec       Impact factor: 0.975

Review 5.  Chemometrics Approaches in Forced Degradation Studies of Pharmaceutical Drugs.

Authors:  Benedito Roberto de Alvarenga Junior; Renato Lajarim Carneiro
Journal:  Molecules       Date:  2019-10-22       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.